Rational Design of PD-1-CD28 Immunostimulatory Fusion Proteins for CAR T Cell Therapy

Investigators compared different PD-1-CD28 immunostimulatory fusion protein variants in a human leukemia model to assess the impact of distinctive design choices on CAR T cell performance in vitro and a xenograft mouse model.